Last updated on August 2017

Study to Evaluate the Efficacy Safety and Tolerability of Mirabegron in Older Adult Subjects With Overactive Bladder (OAB)

Brief description of study

The purpose of this study is to assess the efficacy, safety and tolerability of mirabegron versus placebo in the treatment of older adult subjects with OAB.

Clinical Study Identifier: NCT02216214

Contact Investigators or Research Sites near you

Start Over

Astellas Pharma Global Development, Inc., ...

Site US00091
Brockton, MA United States
  Connect »